Consolidated Financial Highlights - Schedule of Consolidated Financial Highlights (Details) - USD ($) |
9 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
|||||||||||
| Per Common Share Operating Performance | ||||||||||||
| Net Asset Value, Beginning of Period | $ 1,017.15 | $ 1,006.39 | ||||||||||
| Results of Operations: | ||||||||||||
| Net Investment Income/(Loss) | [1] | 47.76 | 41.76 | |||||||||
| Net Realized Gains/(Losses) and Unrealized Appreciation/(Depreciation) | 1.74 | 7.34 | ||||||||||
| Net Increase/(Decrease) in Net Assets Resulting from Operations | 49.5 | 49.1 | ||||||||||
| Distributions to Common Stockholders | ||||||||||||
| Distributions from Net Investment Income | (35.57) | (31.01) | ||||||||||
| Net Decrease in Net Assets Resulting from Distributions | (35.57) | (31.01) | ||||||||||
| Capital Share Transactions | ||||||||||||
| Issuance of Common Stock | (0.08) | |||||||||||
| Net Increase/(Decrease) Resulting from Capital Share Transactions | (0.08) | |||||||||||
| Net Asset Value, End of Period | $ 1,031.08 | $ 1,024.4 | ||||||||||
| Shares Outstanding, End of Period (in Shares) | 100,003.89 | 94,605.04 | ||||||||||
| Ratio/Supplemental Data | ||||||||||||
| Net assets, end of period (in Dollars) | $ 103,111,848 | $ 96,913,420 | ||||||||||
| Weighted-average shares outstanding | [2] | $ 98,174.78 | $ 94,433.73 | |||||||||
| Total Return | [3] | 4.91% | 4.90% | |||||||||
| Portfolio turnover | [4] | 30.55% | 32.94% | |||||||||
| Ratio of total expenses to average net assets with reimbursement | [5] | 2.39% | 2.84% | |||||||||
| Ratio of total expenses to average net assets without reimbursement | [5] | 2.69% | 2.84% | |||||||||
| Ratio of net investment income/(loss) to average net assets with reimbursement | [5] | 6.28% | 5.52% | |||||||||
| ||||||||||||